Mersana Therapeutics, Inc. Operating Lease, Payments
Mersana Therapeutics, Inc. reported Operating Lease, Payments of $3.98 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-03-03
- Mersana Therapeutics, Inc. operating lease, payments for the quarter ending 2019-12-31 was $586.00K.
- Mersana Therapeutics, Inc. operating lease, payments for the quarter ending 2019-09-30 was $585.00K.
- Mersana Therapeutics, Inc. operating lease, payments for the quarter ending 2019-06-30 was $586.00K.
- Mersana Therapeutics, Inc. operating lease, payments for the quarter ending 2019-03-31 was $514.00K.
- Mersana Therapeutics, Inc. operating lease, payments for fiscal 2024 was $3.98M, a 1.34% decline from fiscal 2023.
- Mersana Therapeutics, Inc. operating lease, payments for fiscal 2023 was $4.03M, a 4.24% increase from fiscal 2022.
- Mersana Therapeutics, Inc. operating lease, payments for fiscal 2022 was $3.87M, a 19.25% increase from fiscal 2021.
- Mersana Therapeutics, Inc. operating lease, payments for fiscal 2021 was $3.24M, a 35.38% increase from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.98M 10-K · filed 2025-03-03 | |||
| 2023-12-31 | $4.03M 10-K · filed 2025-03-03 | |||
| 2022-12-31 | $3.87M 10-K · filed 2024-02-28 | |||
| 2021-12-31 | $3.24M 10-K · filed 2023-02-28 | |||
| 2020-12-31 | $2.39M 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $586.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.17M derived: sum of 2 quarters · filed 2021-02-26 | $1.76M derived: sum of 3 quarters · filed 2021-02-26 | $2.27M 10-K · filed 2021-02-26 |
| 2019-09-30 | $585.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.17M derived: sum of 2 quarters · filed 2019-11-06 | $1.69M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $586.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.10M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $514.00K 10-Q · filed 2019-05-09 |